Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer-Reference-Cited by-同舟云学术

Lenalidomide for Second-line Treatment of Advanced Hepatocellular Cancer

Published:2015-02 Issue:1 Volume:38 Page:1-4
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Safran Howard,Charpentier Kevin P.,Kaubisch Andreas,Mantripragada Kalyan,Dubel Gregory,Perez Kimberly,Faricy-Anderson Katherine,Miner Thomas,Eng Yoko,Victor Joel,Plette Angela,Espat Joseph,Bakalarski Pamela,Wingate Patti,Berz David,Luppe Denise,Martel Diane,Rosati Kayla,Aparo Santiago

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference25 articles.

1. . Sorafenib in advanced hepatocellular carcinoma.;Llovet;N Engl J Med,2008

2. . Phase II study of erlotinib (OSI-774) in patients with advanced hepatocellular cancer.;Philip;J Clin Oncol,2005

3. . Orally administered lenalidomide (CC-5013) is antiangiogenic in vivo and inhibits endothelial cell migration and akt phosphorylation in vitro.;Dredge;Microvasc Res,2005

4. . Novel thalidomide analogues display anti-angiogenic activity independently of immunomodulatory effects.;Dredge;Br J Cancer,2002

5. . Immunomodulatory analogs of thalidomide inhibit growth of Hs sultan cells and angiogenesis in vivo.;Lentzsch;Leukemia,2003

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity map;2024-02-07

2. Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity map;2024-01-31

3. Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity map;2024-01-03

4. Tumor relapse-free survival prognosis related consistency between cancer tissue and adjacent normal tissue in drug repurposing for solid tumor via connectivity map;2024-01-03

5. Neutrophils: Driving inflammation during the development of hepatocellular carcinoma;Cancer Letters;2021-12